424 related articles for article (PubMed ID: 15894653)
21. Hormone replacement therapy and mammographic screening.
Evans A
Clin Radiol; 2002 Jul; 57(7):563-4. PubMed ID: 12096852
[TBL] [Abstract][Full Text] [Related]
22. Breast density changes associated with hormone replacement therapy in postmenopausal women. Effects on the specificity and sensitivity of mammographic screening.
Patella A; Marziani R; Schippa A; Benedetti S; Mossa S; Mossa B
Eur J Gynaecol Oncol; 2005; 26(5):485-90. PubMed ID: 16285562
[TBL] [Abstract][Full Text] [Related]
23. Impact of hormone replacement therapy use on mammographic screening outcomes.
Beckmann KR; Farshid G; Roder DM; Hiller JE; Lynch JW
Cancer Causes Control; 2013 Jul; 24(7):1417-26. PubMed ID: 23649232
[TBL] [Abstract][Full Text] [Related]
24. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
[TBL] [Abstract][Full Text] [Related]
25. Using mammographic density to improve breast cancer screening outcomes.
Kavanagh AM; Byrnes GB; Nickson C; Cawson JN; Giles GG; Hopper JL; Gertig DM; English DR
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2818-24. PubMed ID: 18843028
[TBL] [Abstract][Full Text] [Related]
26. Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer.
Boyd NF; Martin LJ; Li Q; Sun L; Chiarelli AM; Hislop G; Yaffe MJ; Minkin S
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):961-6. PubMed ID: 16702377
[TBL] [Abstract][Full Text] [Related]
27. Biennial versus annual mammography and the risk of late-stage breast cancer.
White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
[TBL] [Abstract][Full Text] [Related]
28. High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study.
Sala E; Warren R; McCann J; Duffy S; Luben R; Day N
Int J Epidemiol; 2000 Aug; 29(4):629-36. PubMed ID: 10922338
[TBL] [Abstract][Full Text] [Related]
29. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
[TBL] [Abstract][Full Text] [Related]
30. Physician predictors of mammographic accuracy.
Smith-Bindman R; Chu P; Miglioretti DL; Quale C; Rosenberg RD; Cutter G; Geller B; Bacchetti P; Sickles EA; Kerlikowske K
J Natl Cancer Inst; 2005 Mar; 97(5):358-67. PubMed ID: 15741572
[TBL] [Abstract][Full Text] [Related]
31. Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study.
Azam S; Lange T; Huynh S; Aro AR; von Euler-Chelpin M; Vejborg I; Tjønneland A; Lynge E; Andersen ZJ
Cancer Causes Control; 2018 Jun; 29(6):495-505. PubMed ID: 29671181
[TBL] [Abstract][Full Text] [Related]
32. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy.
Rutter CM; Mandelson MT; Laya MB; Seger DJ; Taplin S
JAMA; 2001 Jan; 285(2):171-6. PubMed ID: 11176809
[TBL] [Abstract][Full Text] [Related]
33. The effect of hormone replacement therapy on the sensitivity of screening mammograms.
Litherland JC; Stallard S; Hole D; Cordiner C
Clin Radiol; 1999 May; 54(5):285-8. PubMed ID: 10362232
[TBL] [Abstract][Full Text] [Related]
34. Influence of lifestyle factors on mammographic density in postmenopausal women.
Brand JS; Czene K; Eriksson L; Trinh T; Bhoo-Pathy N; Hall P; Celebioglu F
PLoS One; 2013; 8(12):e81876. PubMed ID: 24349146
[TBL] [Abstract][Full Text] [Related]
35. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Lund E; Gram IT
Int J Cancer; 2007 Feb; 120(4):880-4. PubMed ID: 17131324
[TBL] [Abstract][Full Text] [Related]
36. Mammographic features and subsequent risk of breast cancer: a comparison of qualitative and quantitative evaluations in the Guernsey prospective studies.
Torres-Mejía G; De Stavola B; Allen DS; Pérez-Gavilán JJ; Ferreira JM; Fentiman IS; Dos Santos Silva I
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1052-9. PubMed ID: 15894652
[TBL] [Abstract][Full Text] [Related]
37. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
[TBL] [Abstract][Full Text] [Related]
38. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.
Georgiev DB; Manassiev NA
Medscape Womens Health; 2002; 7(4):1. PubMed ID: 12466733
[TBL] [Abstract][Full Text] [Related]
39. Influence of hormone replacement therapy on the accuracy of screening mammography.
Vernet Mdel M; Checa MA; Macià F; Casamitjana M; Carreras R
Breast J; 2006; 12(2):154-8. PubMed ID: 16509841
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer in women who undergo screening mammography: relationship of hormone replacement therapy to stage and detection method.
Roubidoux MA; Wilson TE; Orange RJ; Fitzgerald JT; Helvie MA; Packer SA
Radiology; 1998 Sep; 208(3):725-8. PubMed ID: 9722852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
